Assessing the potential of RNA-based therapeutics for a group of Lysosomal Storage Diseases with neurological involvement

During the first two decades of the 21st century, remarkable progresses have been achieved in the field of RNA-based therapeutics. From antisense RNA to RNA modification, the therapeutic potential of RNA-based technologies has nothing but increased. In our lab, we have been addressing the potential...

Full description

Bibliographic Details
Main Author: Santos, Juliana Inês (author)
Other Authors: Gonçalves, Mariana (author), Matos, Liliana (author), Gaspar, Paulo (author), Pires, Maria João (author), Oliveira, Paula (author), Prata, Maria João (author)
Format: conferenceObject
Language:eng
Published: 2022
Subjects:
Mucopolysaccharidosis III
Lysosomal Storage Diseases
Doenças Lisossomais de sobrecarga
Mucopolissacaridose III
Doenças Genéticas
Genética Humana
Online Access:http://hdl.handle.net/10400.18/7990
Country:Portugal
Oai:oai:repositorio.insa.pt:10400.18/7990

Internet

http://hdl.handle.net/10400.18/7990

Similar Items